Tyson Foods Q1 Earnings Beat Estimates, Revenue Miss

Tyson Foods, Inc. TSN offers a wide array of meat products and commands a strong presence in all beef, pork, chicken and processed food products categories.

Continuous product innovations and strong momentum in most of its business segments is driving sales of the company since past many quarters. With a general shift of demand among health conscious consumers from red meat to low-calorie chicken and processed chicken food items, Tyson's endeavor to offer low-calorie protein foods like NatureRaised Farms brand is encouraging. Due to this, investors are eagerly awaiting Tyson's earnings report.

Investors should also note the recent earnings estimate revisions for TSN, as the consensus estimate has been moving higher. Moreover, TSN has a mixed history in earnings season. Tyson has delivered positive surprise in two of the last four quarters, with negative surprises in the other two, making for an average surprise of negative 3.47%.

Currently, Tyson Foods has a Zacks Rank #2 (Buy), but that could definitely change following Tyson's earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: Tyson Foods beats on earnings. Our consensus called for EPS of 87 cents, and the company reported EPS of $1.15 per share instead. Investors should note that these figures take out stock option expenses.

Revenue: Tyson Foods posted revenues of $9.15 billion. This missed our consensus estimate by $10.12 billion.

Key Stats to Note: Operating income increased 37.6% to $776 million.

Check back later for our full write up on this TSN earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days .Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
TYSON FOODS A (TSN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement